** Shares of Orthocell fall as much as 10.1% to A$0.620, posting their biggest intraday pct loss since March 16, 2023

** Biotech firm says it will raise A$17 mln ($11.28 mln) via placement of 28.3 mln shares

** Issue price of A$0.60 per share is at a 13% discount to stock's last close

** Co says funds will be used to launch its nerve repair medical device Remplir in the United States

** Stock hits lowest level since Oct. 14

** About 1.2 mln shares change hands, 1.5x the 30-day avg

** Stock up 62.3% YTD, as of 0308 GMT

($1 = 1.5076 Australian dollars)

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com;))